CEO Mauch’s Minor Cencora Sale Post‑Merge Signals Routine Liquidity, Not Low Confidence
CEO Robert Mauch sells 1,333 Cencora shares after a $3.5B merger, a routine liquidity move that still supports the company’s premium valuation and future veterinary tech growth.
3 minutes to read